as 07-26-2024 4:00pm EST
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
Founded: | 1986 | Country: | United States |
Employees: | N/A | City: | N/A |
Market Cap: | 904.2M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 183.8K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 1.09 | EPS Growth: | N/A |
52 Week Low/High: | $14.31 - $17.94 | Next Earning Date: | 01-01-0001 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Reit Todd | HQH | Director | Jan 2 '24 | Buy | $16.93 | 1,000 | $16,929.00 | 1,000 | SEC Form 4 |
Maher Bill | HQH | Director | Dec 28 '23 | Buy | $16.58 | 1,000 | $16,580.00 | 1,000 | SEC Form 4 |
Goodson Alan R | HQH | Vice President | Dec 21 '23 | Buy | $16.13 | 170 | $2,742.10 | 170 | SEC Form 4 |
HQH Breaking Stock News: Dive into HQH Ticker-Specific Updates for Smart Investing
Argus Research
7 days ago
Argus Research
7 days ago
ACCESSWIRE
a month ago
ACCESSWIRE
a month ago
ACCESSWIRE
3 months ago
ACCESSWIRE
4 months ago
ACCESSWIRE
4 months ago
ACCESSWIRE
6 months ago
The information presented on this page, "HQH abrdn Healthcare Investors Shares of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.